A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin mimetic, for the treatment of adult patients with polycythemia vera (PV). 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback